Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research

Value in Health

Volumn 19, Issue 8, 2016, Pages 929-935

  Woods, Beth ^a   Revill, Paul ^a   Sculpher, Mark ^a   Claxton, Karl ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

benefits package; cost effectiveness; quality adjusted life years; threshold; universal health care; willingness to pay

Indexed keywords

ARTICLE; CAMBODIA; COST EFFECTIVENESS ANALYSIS; COUNTRY ECONOMIC STATUS; EL SALVADOR; EMPIRICAL RESEARCH; GROSS NATIONAL PRODUCT; HEALTH CARE COST; KAZAKHSTAN; MALAWI; PRIORITY JOURNAL; PUBLIC HEALTH; COST BENEFIT ANALYSIS; DEVELOPING COUNTRY; ECONOMICS; GLOBAL HEALTH; HEALTH CARE ORGANIZATION; HUMAN; PROCEDURES; QUALITY ADJUSTED LIFE YEAR;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; GLOBAL HEALTH; GROSS DOMESTIC PRODUCT; HEALTH CARE RATIONING; HEALTH EXPENDITURES; HUMANS; QUALITY-ADJUSTED LIFE YEARS;

EID: 85006116968     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2016.02.017     Document Type: Article

References (39)

1. [1] Drummond, M.F., Sculpher, M.J., Claxton, K., et al. Methods for the Economic. Evaluation of Health Care Programmes, 4th ed.), 2015, Oxford University Press, Oxford, UK.
2. [2] Palmer, S., Raftery, J., Economic notes: opportunity cost. BMJ 318 (1999), 1551–1552.
3. [3] Claxton K, Walker S, Palmer S, Sculpher M. Appropriate perspectives for health care decisions. CHE Research Paper 54, Centre for Health Economics, University of York, 2010.
4. [4] Claxton K, Martin S, Soares M, et al. Methods for the estimation of the NICE cost-effectiveness threshold. CHE Research Paper 81, Centre for Health Economics, University of York, 2013.
5. [5] Neumann, P.J., Cohen, J.T., Weinstein, M.C., Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. N Engl J Med 371 (2014), 796–797 Available from: http://www.ncbi.nlm.nih.gov/pubmed/25692211. [Accessed December 2014].
6. [6] Claxton K., Martin S., Soares M., et al. Written evidence to the House of Commons Health Select Committee on the NICE cost-effectiveness threshold. 2013. Available from: http://www.publications.parliament.uk/pa/cm201213/cmselect/cmhealth/782/782vw55.htm. [Accessed December 2014].
7. [7] World Health Organization. World Health Organization, cost-effectiveness thresholds. 2012. Available from: 〈http://www.who.int/choice/costs/CER_thresholds/en/index.html〉. [Accessed April 30, 2012].
8. [8] World Health Organization. Macroeconomics and Health: Investing in Health for Economic Development, 2001, World Health Organization, Geneva, Switzerland.
9. [9] Jamison, D.T., Summers, L.H., Alleyne, G., et al. Global health 2035: a world converging within a generation. Lancet 382 (2013), 1898–1955.
10. [10] Revill P, Walker S, Madan J, et al. Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: are current international norms fit for purpose? CHE Research Paper 98, Centre for Health Economics, University of York, 2014.
11. [11] Newall, A.T., Jit, M., Hutubessy, R., Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines. Pharmacoeconomics 32 (2014), 525–531.
12. [12] Moreno-Serra, R., Smith, P.C., Does progress towards universal health coverage improve population health?. Lancet 380 (2012), 917–923.
13. [13] Moreno-Serra, R., Smith, P.C., Broader health coverage is good for the nation׳s health: evidence from country level panel data. J R Stat Soc Ser A Stat Soc 178 (2015), 101–124.
14. [14] Bokhari, F.A., Gai, Y., Gottret, P., Government health expenditures and health outcomes. Health Econ 16 (2007), 257–273.
15. [15] Farahani, M., Subramanian, S.V., Canning, D., Effects of state-level public spending on health on the mortality probability in India. Health Econ 19 (2010), 1361–1376.
16. [16] Shiroiwa, T., Sung, Y.K., Fukuda, T., et al. International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?. Health Econ 19 (2010), 422–437.
17. [17] Ryen, L., Svensson, M., The willingness to pay for a quality adjusted life year: a review of the empirical literature. Health Econ [Epub ahead of print], July 28, 2014, 10.1002/hec.3085.
18. [18] Viscusi, W.K., Aldy, J.E., The value of a statistical life: a critical review of market estimates throughout the world. J Risk Uncertain 27 (2003), 5–76.
19. [19] Hammitt, J.K., Robinson, L.A., The income elasticity of the value per statistical life: transferring estimates between high and low income populations. J Benefit Cost Anal 2 (2011), 2152–2812.
20. [20] The World Bank. PPP conversion factor, GDP (LCU per international $). 2014. Available from: 〈http://data.worldbank.org/indicator/PA.NUS.PPP〉 [Accessed December 2014].
21. [21] The World Bank. GDP per capita, PPP (current international $). 2014. Available from: http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD [Accessed December 2014].
22. [22] Milligan, C., Kopp, A., Dahdah, S., Montufar, J., Value of a statistical life in road safety: a benefit-transfer function with risk-analysis guidance based on developing country data. Accid Anal Prev 71 (2014), 236–247.
23. [23] The World Bank. GDP per capita (current US$). 2014. Available from: 〈http://data.worldbank.org/indicator/NY.GDP.PCAP.CD〉 [Accessed December 2014].
24. [24] The World Bank. Price level ratio of PPP conversion factor (GDP) to market exchange rate. 2014. Available from: 〈http://data.worldbank.org/indicator/PA.NUS.PPPC.RF〉 [Accessed December 2014].
25. [25] Getzen, T.E., Health care is an individual necessity and a national luxury: applying multilevel decision models to the analysis of health care expenditures. J Health Econ 19 (2000), 259–270.
26. [26] Aldy JE, Smyth SJ. Heterogeneity in the value of life. NBER Working Paper No. 20206, National Bureau of Economic Research, 2014.
27. [27] Besley, T., Persson, T., Why do developing countries tax so little?. J Econ Perspect 28 (2014), 99–120.
28. [28] Farag, M., Nandakumar, A., Wallack, S.S., et al. Does funding from donors displace government spending for health in developing countries?. Health Aff 28 (2009), 1045–1055.
29. [29] Vallejo-Torres L, Garcia-Lorenzo B, Castilla I, et al. On the estimation of the monetary value of a QALY: is the dilemma really over? Working Paper. Conference paper presented at the Health Economics Study Group in Leeds, UK in 2015 (7th to 9th January).
30. [30] Martin, S., Rice, N., Smith, P.C., Does health care spending improve health outcomes? Evidence from English programme budgeting data. J Health Econ 27 (2008), 826–842.
31. [31] Martin, S., Rice, N., Smith, P.C., Comparing costs and outcomes across programmes of health care. Health economics 21:3 (2012 Mar 1), 316–337.
32. [32] Lichtenberg, F.R., Sources of US longevity increase, 1960–2001. Q Rev Econ Finance 44 (2004), 369–389.
33. [33] Claxton, K., Martin, S., Soares, M., et al. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol Assess 19 (2015), 1–503.
34. [34] Claxton K, Sculpher M. Response to the OHE critique of CHE Research Paper 81. 2015. Available from: https://www.york.ac.uk/media/che/documents/Response%20to%20the%20OHE%20critique%20of%20CHE%20Research%20paper%2081.pdf. [Accessed December 2014].
35. [35] Ochalek J, Claxton K, Lomas J. Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data. Working Paper, Centre for Health Economics, University of York, 2015.
36. [36] Culyer, A., McCabe, C., Briggs, A., et al. Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence. J Health Serv Res Policy 12 (2007), 56–58.
37. [37] Bowie, C., Mwase, T., Assessing the use of an essential health package in a sector wide approach in Malawi. Health Res Policy Syst, 9, 2011, 4.
38. [38] Stinnett, A.A., Paltiel, A.D., Mathematical programming for the efficient allocation of health care resources. J Health Econ 15 (1996), 641–653.
39. [39] Epstein, D.M., Chalabi, Z., Claxton, K., Sculpher, M., Efficiency, equity, and budgetary policies: informing decisions using mathematical programming. Med Decis Making 27 (2007), 128–137.